Fintel reports that on July 3, 2023, Morgan Stanley maintained coverage of Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 128.93% Upside
© Reuters. FILE PHOTO: A seagull eats a fish thrown away by fishermen after it was damaged with a net and couldn’t be sold, at
In this episode of StockCharts TV‘s The Final Bar, Part 1 of a two-part special examining the Top Ten Stocks to Watch in July 2023, Dave covers
© Reuters. FILE PHOTO: The logo of car manufacturer Tesla is seen at a dealership in London, Britain, May 14, 2021. REUTERS/Matthew Childs/File Photo/File Photo
The 2023 Super Bowl was a great one. It started with a strong first half for the Philadelphia Eagles. The Eagles fans were soaring with
Fintel reports that on July 3, 2023, Chardan Capital reiterated coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,450.00% Upside As
© Reuters. Investing.com — AstraZeneca (LON:) has announced that its experimental precision drug has shown improvement in slowing the progression of lung cancer in a late-stage
KEY TAKEAWAYS The Nasdaq 100 Index ($NDX) has outperformed the S&P 500, DJIA, and Nasdaq Composite Momentum indicators can help identify a slowing down in
© Reuters. FILE PHOTO: DirecTV satellite dishes are seen on an apartment roof in Los Angeles, California in this file photo taken May 18, 2014.
Three weeks before the Fed’s next meeting, investors who have missed the AI/tech rally have thrown caution to the wind. That urgency to catch up